Tower Research Capital LLC (TRC) - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 17 filers reported holding VIRIOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,112
+157.1%
8,770
+283.6%
0.00%
Q2 2023$3,155
-47.4%
2,286
+53.7%
0.00%
Q2 2022$6,000
-50.0%
1,487
-43.6%
0.00%
Q1 2022$12,0002,636
+8686.7%
0.00%
Q4 2021$0
-100.0%
30
-98.8%
0.00%
Q3 2021$13,000
+30.0%
2,403
+57.4%
0.00%
Q2 2021$10,000
+150.0%
1,527
+120.0%
0.00%
Q1 2021$4,0006940.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
McCollum Christoferson Group LLC 33,300$30,7960.01%
&PARTNERS 11,000$10,1730.01%
Virtu Financial LLC 27,322$250.00%
XTX Topco Ltd 14,441$13,3550.00%
RAYMOND JAMES & ASSOCIATES 30,000$27,7440.00%
WELLS FARGO & COMPANY/MN 124$1150.00%
NORTHERN TRUST CORP 24,035$22,2280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 11,482$10,6190.00%
GEODE CAPITAL MANAGEMENT, LLC 174,469$161,3750.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders